ProKidney Corp
PROK2.890USD
+0.080+2.85%
收盘 11/07, 16:00（美东）报价延迟15分钟
385.58M总市值
亏损市盈率 TTM
关于 ProKidney Corp 公司
ProKidney Corp. 是一家临床阶段的生物技术公司。该公司专注于细胞治疗平台，该平台能够使用从患者身上分离出来的细胞来治疗多种慢性肾脏疾病 (CKD)。该公司的主要候选产品肾自体细胞疗法 (REACT) 旨在保留 CKD 患者患病肾脏的肾功能。REACT 是一种产品，包括从患者自身（自体）肾细胞制备的自体选择肾细胞 (SRC)。REACT 注射剂是一种研究性疗法，是从参与者自身肾脏组织制备的肾细胞混合物。其专利技术包括细胞治疗产品的制造和医疗输送方面的多项突破。该公司正在针对中度至重度糖尿病肾病 (DKD) 患者开展 REACT 的全球 3 期开发计划和多项 2 期临床试验。
ProKidney Corp简介
公司代码PROK
公司名称ProKidney Corp
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
员工数量204
证券类型Ordinary Share
年结日Jun 30
公司地址2000 Frontis Plaza Blvd.
城市WINSTON-SALEM
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编27103
电话13369997028
网址https://prokidney.com/
公司代码PROK
上市日期Jun 30, 2021
CEODr. Bruce Culleton, M.D.
ProKidney Corp公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. Ethan Holdaway
Mr. Ethan Holdaway
Investor Relations
Investor Relations
--
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Independent Director
Independent Director
--
--
Dr. Alan M. Lotvin, M.D.
Dr. Alan M. Lotvin, M.D.
Independent Director
Independent Director
--
--
Dr. Darin J. Weber, Ph.D.
Dr. Darin J. Weber, Ph.D.
Chief Regulatory Officer, Senior Vice President- Global Regulatory, Quality Management & Commercial
Chief Regulatory Officer, Senior Vice President- Global Regulatory, Quality Management & Commercial
--
--
Dr. Brian J. G. Pereira, M.D.
Dr. Brian J. G. Pereira, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Bruce Culleton, M.D.
Dr. Bruce Culleton, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.54M
--
Mr. Ethan Holdaway
Mr. Ethan Holdaway
Investor Relations
Investor Relations
--
--
Mr. William F. (Bill) Doyle
Mr. William F. (Bill) Doyle
Independent Director
Independent Director
--
--
Mr. Pablo Legorreta
Mr. Pablo Legorreta
Chairman of the Board
Chairman of the Board
--
--
Dr. Uma Sinha, Ph.D.
Dr. Uma Sinha, Ph.D.
Independent Director
Independent Director
--
--
Mr. James Coulston, CPA
Mr. James Coulston, CPA
Chief Financial Officer
Chief Financial Officer
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 11月8日 周六
更新时间: 11月8日 周六
持股股东
股东类型
持股股东
持股股东
占比
Tolerantia LLC
16.75%
Suvretta Capital Management, LLC
9.14%
Control Empresarial de Capitales, S.A. de C.V.
7.94%
Morgan Stanley Investment Management Inc. (US)
4.23%
BlackRock Mexico Operadora SA de CV SOFI
2.54%
其他
59.39%
持股股东
持股股东
占比
Tolerantia LLC
16.75%
Suvretta Capital Management, LLC
9.14%
Control Empresarial de Capitales, S.A. de C.V.
7.94%
Morgan Stanley Investment Management Inc. (US)
4.23%
BlackRock Mexico Operadora SA de CV SOFI
2.54%
其他
59.39%
股东类型
持股股东
占比
Corporation
24.70%
Hedge Fund
10.27%
Investment Advisor
10.23%
Investment Advisor/Hedge Fund
5.98%
Research Firm
2.84%
Individual Investor
1.92%
Endowment Fund
0.74%
Family Office
0.04%
Bank and Trust
0.04%
其他
43.25%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
180
38.60M
28.59%
-15.99M
2025Q2
187
92.52M
71.43%
-12.19M
2025Q1
188
90.99M
70.46%
-13.35M
2024Q4
184
92.39M
74.12%
+21.48M
2024Q3
176
90.75M
73.53%
+26.28M
2024Q2
216
81.85M
70.67%
+19.77M
2024Q1
231
37.73M
58.52%
-31.32M
2023Q4
239
39.92M
63.74%
-31.95M
2023Q3
236
64.28M
104.12%
-21.16M
2023Q2
223
59.02M
95.83%
-21.49M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Tolerantia LLC
22.62M
16.75%
--
--
Jun 03, 2025
Suvretta Capital Management, LLC
12.34M
9.14%
--
--
Jun 30, 2025
Control Empresarial de Capitales, S.A. de C.V.
10.72M
7.94%
+2.28M
+27.04%
Apr 22, 2025
Morgan Stanley Investment Management Inc. (US)
5.71M
4.23%
-4.33M
-43.14%
Jun 30, 2025
BlackRock Mexico Operadora SA de CV SOFI
3.43M
2.54%
--
--
Aug 31, 2025
Operadora de Fondos GBM S.A.B. de C.V.
2.45M
1.81%
--
--
Aug 31, 2025
Bleichroeder LP
2.00M
1.48%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.72M
1.27%
-4.60M
-72.83%
Jun 30, 2025
The Vanguard Group, Inc.
1.57M
1.16%
-3.64M
-69.92%
Jun 30, 2025
Culleton (Bruce)
1.54M
1.14%
+1.54M
--
Mar 17, 2025
查看更多
持股ETF
更新时间: 11月6日 周四
更新时间: 11月6日 周四
机构名称
占比
Schwab U.S. Small-Cap ETF
0.01%
ALPS Medical Breakthroughs ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Schwab U.S. Broad Market ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
Avantis US Equity ETF
0%
Global X Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
查看更多
Schwab U.S. Small-Cap ETF
占比0.01%
ALPS Medical Breakthroughs ETF
占比0%
Global X Russell 2000 Covered Call ETF
占比0%
Schwab U.S. Broad Market ETF
占比0%
ProShares UltraPro Russell2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 ETF
占比0%
Avantis US Equity ETF
占比0%
Global X Russell 2000 ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
